tiprankstipranks
Trending News
More News >
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market
Advertisement

CStone Pharmaceuticals (2616) Financial Statements

Compare
3 Followers

CStone Pharmaceuticals Financial Overview

CStone Pharmaceuticals's market cap is currently HK$10.76B. The company's EPS TTM is HK$-0.2293234839; its P/E ratio is ―; CStone Pharmaceuticals is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is HK$-0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in CNY

CStone Pharmaceuticals Earnings and Revenue History

CStone Pharmaceuticals Debt to Assets

CStone Pharmaceuticals Cash Flow

CStone Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis